Source: https://patents.google.com/patent/US9731119
Timestamp: 2018-02-24 22:14:54
Document Index: 367359934

Matched Legal Cases: ['Application No. 61', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42', 'art 42']

US9731119B2 - System and method for implantable medical device lead shielding - Google Patents
System and method for implantable medical device lead shielding
US9731119B2
US9731119B2 US14715271 US201514715271A US9731119B2 US 9731119 B2 US9731119 B2 US 9731119B2 US 14715271 US14715271 US 14715271 US 201514715271 A US201514715271 A US 201514715271A US 9731119 B2 US9731119 B2 US 9731119B2
Active, expires 2028-05-23
US14715271
US20150246222A1 (en )
Mark T. Marshall
An implantable medical device (IMD) can include a cardiac pacemaker or an implantable cardioverter-defibrillator (ICD). Various portions of the IMD, such as a device body, a lead body, or a lead tip, can be provided to reduce or dissipate a current and heat induced by various external environmental factors. According to various embodiments, features can be incorporated into the lead body, the lead tip, or the IMD body to reduce the creation of an induced current, or dissipate the induced current and heat created due to an induced current in the lead. For example, an IMD can include at least one outer conductive member and a first electrode. The first electrode can be in electrical communication with the at least one outer conductive member. The first electrode can dissipate a current induced in the at least one outer conductive member via a first portion of the anatomical structure.
This application claims the benefit of U.S. Provisional Application No. 61/035,956, filed on Mar. 12, 2008. The disclosure of the above application is incorporated herein by reference.
The present disclosure relates to implantable medical devices (IMDs), in particular to a system and method for shielding a cardiac lead system from radio frequency (RF) energy.
The human anatomy includes many types of tissue that can either voluntarily or involuntarily, perform certain functions. However, after disease or injury, certain tissues may no longer operate within general anatomical norms. For example, after disease, injury, age, or combinations thereof, the heart muscle may begin to experience certain failures or deficiencies. Some of these failures or deficiencies can be corrected or treated with IMDs. These devices can include implantable pulse generator (IPG) devices, pacemakers, implantable cardioverter-defibrillator (ICD) devices, cardiac resynchronization therapy defibrillator devices, or combinations thereof.
One of the main portions of the IMD can include a lead that is directly connected to tissue to be affected by the IMD. The lead can include a tip portion that is directly connected to the anatomical tissue, such as a muscle bundle, and a lead body that connects to the device body or therapeutic driving device. It is generally known that the device body or case portion can be implanted in a selected portion of the anatomical structure, such as in a chest or abdominal wall, and the lead can be inserted through various venous portions so that the tip portion can be positioned at the selected position near or in the muscle group.
The IMD generally remains with the patient during the rest of the patient's natural life. To that end, the IMD can be exposed to various environmental factors. For example, the patient may undergo a magnetic resonance imaging (MRI) procedure or other high frequency imaging procedures. In this case, portions of the IMD may act as an antenna and have current and thermal energy induced therein due to the MRI procedure. Accordingly, reduction or dissipation of the induced current or thermal energy may be useful in certain circumstances.
An implantable medical device (IMD) can include implantable pulse generator (IPG) devices, implantable cardioverter-defibrillators (ICD), cardiac resynchronization therapy defibrillator devices, neurostimulators or combinations thereof. The IMD can be positioned in a selected portion of the anatomical structure, such as a chest wall or abdominal wall, and a lead can be positioned through a vein or transvenously so that a lead tip can be implanted in a portion of the cardiac or heart muscle. Various portions of the IMD, such as a case or device body, the lead body, or the lead tip, can be formed or augmented to reduce or dissipate heat production due to various external environmental factors. For example, a magnetic and/or electric field from a magnetic resonance imager (MRI), diathermy (including shortwave, microwave, ultrasound, or the like) or other energy field producing devices can induce currents in the lead. According to various embodiments, features or portions can be incorporated into the lead body, the lead tip, or the device body to reduce the creation of an induced current, or dissipate or increase the area of dissipation of thermal energy created due to an induced current in the lead.
An implantable medical device operable to provide a therapy to an anatomical structure is provided. The device can include a lead having a proximal end, a distal end and at least one outer conductive member and a multilumen member that extends from the proximal end to the distal end. The device can also include a first electrode fixedly coupled between the proximal end and the distal end of the lead such that the first electrode can be positioned adjacent to a first portion of the anatomical structure, the first electrode in electrical communication with a first inner conductor disposed within the multilumen member to deliver a therapy to the first portion of the anatomical structure. The first electrode can be in electrical communication with the at least one outer conductive member and can have a first surface area. The device can also include a second electrode that can be coupled to the distal end of the lead. The second electrode in electrical communication with a second inner conductor disposed within the multilumen member to deliver a therapy to a second portion of the anatomical structure. The second electrode can have a second surface area. The first surface area can be greater than the second surface area. The first electrode can dissipate a current induced in the at least one outer conductive member via the first portion of the anatomical structure.
Provided is an implantable medical device operable to provide a therapy to an anatomical structure. The device can include a therapy device implanted in a portion of the anatomical structure and operable to generate the therapy for the anatomical structure. The device can also include a lead having a proximal end, a distal end and a lead body that includes a first outer conductive braid, a second outer conductive braid and a multilumen member. The first outer conductive braid and the second outer conductive braid can be disposed about the multilumen member. The device can include a first electrode fixedly coupled between the proximal end and the distal end of the lead such that the first electrode is positioned adjacent to a first portion of the anatomical structure. The first electrode can be in communication with the first outer conductive braid and the second outer conductive braid. The device can also include a first inner conductor that can pass through a portion of the multilumen member. The first inner conductor can be in electrical communication with the first electrode to deliver a therapy to the first portion of the anatomical structure. The device can include a tip electrode extending beyond the distal end of the lead and a tip inner conductor that can pass through a portion of the multilumen member. The tip inner conductor can be in electrical communication with the tip electrode to deliver a therapy to a second portion of the anatomical structure. The device can include a second electrode coupled adjacent to the tip electrode at the distal end of the lead such that the second electrode is positioned adjacent to a third portion of the anatomical structure. The device can further include a second inner conductor that can pass through a portion of the multilumen member. The second inner conductor can be in electrical communication with the second electrode to deliver a therapy to the third portion of the anatomical structure. The first outer conductive braid can be disposed between the proximal end of the lead and the first electrode, and the second outer conductive braid can be disposed between the first electrode and the second electrode. The first electrode can dissipate a current induced in the first outer conductive braid and second outer conductive braid, via the first portion of the anatomical structure.
Further provided is a method of forming a cardiac lead system for implantation into an anatomical structure. The method can include providing a lead having a multilumen member that can pass through the lead, a first electrode in electrical communication with a first inner conductor and fixedly coupled to the multilumen member, the first inner conductor passing through a portion of the multilumen member, and a second electrode in electrical communication with a second inner conductor and extending beyond an end of the multilumen member, the second inner conductor passing through a portion of the multilumen member. The method can also include providing the first electrode with a first surface area and the second electrode with a second surface area, with the first surface area being larger than the second surface area. The method can include covering a substantial portion of the lead with a shield, and electrically coupling the shield to the first electrode.
FIG. 1 is a view of an IMD including a lead connected to a device body;
FIG. 2 is a simplified environmental view of an IMD implanted in a patient;
FIG. 3 is an environmental view of an ICD implanted in a patient that includes an exemplary shielded cardiac lead system;
FIG. 4 is a perspective view of the exemplary shielded cardiac lead system according to various embodiments;
FIG. 5 is a perspective cut away view of the cardiac lead system of FIG. 4 taken along line 5-5 of FIG. 4; and
FIG. 6 is a cross-sectional view of the cardiac lead system of FIG. 4 taken along line 6-6 of FIG. 4.
The following description is merely exemplary in nature and is not intended to limit the present disclosure, application, or uses. It should be understood that throughout the drawings, corresponding reference numerals indicate like or corresponding parts and features. As indicated above, the present teachings are directed towards providing a system and method for shielding a cardiac lead system from RF energy. It should be noted, however, that the present teachings could be applicable to any appropriate procedure in which it is desirable to shield a component from external electrical fields. Therefore, it will be understood that the following discussions are not intended to limit the scope of the appended claims.
With reference to FIG. 1, an implantable medical device (IMD) 20, which can include implantable pulse generator (IPG) devices, implantable cardioverter-defibrillator (ICD) devices, cardiac resynchronization therapy defibrillator devices, or combinations thereof, is exemplarily illustrated. The IMD 20 can include an implantable case or body assembly 22. The implantable case 22 can be formed of appropriate materials and include appropriate features, such as a hermetically sealed body wall 24. The body wall 24 can be made of a substantially inert material or of a conducting material.
Contained within or associated with the case 22 can be a power device 25 (i.e., battery), a controller assembly 26, and a connector body 27. The controller assembly 26 can include a circuit board having a processor, memory, transmitter, receiver, and other appropriation portions, further discussed herein. The connector body 27 can extend from or be integrated with the case 22. The connector body 27 can include multiple ports 28 that each interconnect with a connector terminal 30 of a lead assembly 32. FIG. 1 illustrates two lead assemblies 32 a, 32 b where each lead assembly 32 a, 32 b includes lead bodies 34 a, 34 b extending from tip electrodes 36 a, 36 b. Although the IMD 20 is illustrated in FIGS. 1 and 2 as including two lead assemblies 32 a, 32 b, it will be understood that any number of lead assemblies 32 could be employed with the IMD 20 depending upon the malady of the patient and the particular IMD 20 employed. Moreover, the switch assembly further discussed herein can be associated with one or all of the lead assemblies 32 a, 32 b for the particular IMD 20 employed.
A fixation mechanism can also be included with each lead assembly 32 a, 32 b to affix each tip electrode 36 a, 36 b relative to or in a selected tissue of the patient. The fixation mechanism can be near each tip electrode 36 a, 36 b or define a portion of the tip electrode 36 a, 36 b. Fixation mechanisms can be any appropriate type, including a grapple mechanism, a helical mechanism, a drug-coated connection mechanism, and other appropriate connection mechanisms.
A majority of each lead body 34 a, 34 b can also be formed in a generally known and selected manner. For example, the various conductors and electrical components can be encased in silicone, polyurethane, and other appropriate materials. For example, at least one inner conductor 136 (FIG. 5) can extend from each connector terminal 30 to engage each tip electrode 36 a, 36 b (identified as 132 d in FIG. 4). It will be understood by one skilled in the art, the inner conductor 136 can be one piece or multiple components that are interconnected. Also, more than one conductor can be provided, such as one conductor for each electrode in each lead assembly 32 a, 32 b. The inner conductor 136 can also be cannulated or include a solid or non-cannulated cable. The casing material of each lead body 34 a, 34 b can electrically insulate the inner electrical conductor from an external environment.
The IMD 20, including the components discussed above, can be implanted in a patient 40 as illustrated in FIG. 2. The IMD 20 can include one or more lead assemblies 32, such as the first lead assembly 32 a and the second lead assembly 32 b. The first lead assembly 32 a and the second lead assembly 32 b can be connected to the connector body 27. As one skilled in the art will understand, the position of lead bodies 34 a, 34 b can depend upon the type of IMD and the malady of the patient 40. For example, the lead assemblies 32 a, 32 b can be positioned transvenously to positions within a heart 42 or on the outside of the heart 42. The IMD 20 can be provided to pace the heart 42, defibrillate the heart 42, sense conditions of the heart 42, etc.
The IMD 20, including the case 22 and the lead bodies 34 a, 34 b, can be implanted using known procedures. For example, an incision can be made in a chest wall or an abdomen wall of the patient 40 and the lead assemblies 32 a, 32 b can be passed through selected veins to selected portions of the heart 42 of the patient 40. The case 22 can also be positioned through the incision into a chest wall or abdominal wall of the patient 40. In a selected procedure, the leads assemblies 32 a, 32 b can be passed through a superior vena cava 44 of the patient 40. The lead tips or tip electrodes 36 a, 36 b can be positioned at various positions in the heart 42, such as at the ventricles or atriums thereof. The position of the lead assemblies 32 a, 32 b and tip electrodes 36 a, 36 b can be selected for pacing, defibrillation, sensing, or other appropriate procedures. The specific implantation procedure, position of the tip electrodes 36 a, 36 b, and the like can depend upon the patient 40, the surgeon performing the procedure, the specifics of the lead assemblies 32 a, 32 b, or other considerations.
As discussed above, the IMD 20, including the case 22 and the lead assemblies 32 a, 32 b can include various features or controls to defibrillate or pace the heart 42. The controls can include a processor associated with the controller assembly 26 located within the case 22. The processor can be programmed to control driving a current through the lead bodies 34 a, 34 b to the tip electrodes 36 a, 36 b to defibrillate or pace the heart 42.
With continued reference to FIG. 2, a programmer or programming system 50 can be provided. The programmer 50 can include a telemetry system that is operable to wirelessly transmit a signal to the processor within the case 22. It will be understood that a wired communication system can also be used. In addition, an induction system can be used where a coil is positioned near the case 22 and a signal is sent from the programmer 50 via induction. The programmer 50 can also receive information from the IMD 20 (e.g. tachycardia rhythms, times and programming settings) to assist in providing an appropriate program for therapy and to determine if the IMD 20 is operating properly. The programmer 50 can include any appropriate programming system, including one generally known to those skilled in the art, such as the Medtronic CARELINK™ programmer, sold by Medtronic, Inc. of Minneapolis, Minn.
Moreover, the IMD 20, including the case 22 and the lead assemblies 32 a, 32 b, can be formed to counteract or interact with various environmental factors. For example, the lead assemblies 32 a, 32 b can include features or portions to re-direct or dissipate thermal energy created by an induced current. Induced currents can be created due to an external field, such as an electromagnetic field acting on the conductors of the lead assemblies 32 a, 32 b.
For example, according to various embodiments, the patient 40 which has the implanted IMD 20 may receive a certain therapy or diagnostic technique, such as a magnetic resonance image (MRI) scan. Although not illustrated, a MRI, generally understood by one skilled in the art, uses high frequency electromagnetic pulses and strong magnetic fields to create image data regarding the patient 40. Generally, a MRI will have a frequency of about 42 MHz per tesla. Many common MRI systems use about 1.5 tesla magnetic fields and have a corresponding RF frequency of about 63 MHz. Without being bound by the theory, the strong magnetic fields in a MRI can induce aligned spins of sub-atomic particles and the high frequency RF pulses can be used to change the alignment or otherwise affect the sub-atomic particles within the patient 40.
The strong magnetic fields and electromagnetic pulses may induce currents within the lead assemblies 32 a, 32 b of the IMD 20. The current induced in the lead assemblies 32 a, 32 b may cause certain affects, including heating, of the various lead components. According to various embodiments, such as those discussed herein, components, controls and/or mechanisms can be provided to reduce or eliminate the amount of current or thermal energy induced within each tip electrode 36 a, 36 b, or increase an area over which the current or thermal energy can be dissipated.
According to various embodiments, with reference to FIG. 3, the IMD 20 can comprise an implantable cardiac device, such as an implantable cardioverter-defibrillator (ICD) 120. As the ICD 120 that will be described herein with reference to FIGS. 3-6 can be similar to the IMD 20 described with reference to FIGS. 1-2, similar reference numerals will be used to denote like components. With continued reference to FIG. 3, the ICD 120 can be used to detect and treat cardiac arrhythmias, and thus, can deliver a therapy to a desired location within the heart 42. In this regard, the ICD 120 can provide anti-tachycardia pacing, cardioversion, defibrillation, and/or bradycardia pacing, while also monitoring the heart rhythm to determine if a therapy is needed. As the ICD 120 can comprise any suitable ICD, such as the ENTRUST™ family of ICDs available from Medtronic, Inc. of Minneapolis, Minn., the ICD 120 will not be discussed in great detail herein. Briefly, however, the ICD 120 can include at least one ICD lead 122, which can be implanted into an anatomical structure, such as the heart 42. The ICD 120 can comprise a single chamber ICD that includes one lead 122 (as illustrated), a dual chamber ICD that includes two leads or a biventricular ICD that includes three leads. The lead 122 can both sense the electrical activity of the heart 42 and can also deliver electrical energy to pace the heart 42. The lead 122 can include a proximal end 124, a distal end 126, a body 128 and at least one electrode assembly 130.
As will be discussed further herein, each electrode assembly 130 can include an electrode 132 and a transmission member 134, which includes an inner conductor 136 and an insulative member 138. Briefly, the electrode 132 can be in contact with the anatomical structure to deliver a therapy to the anatomical structure, such as an electrical pulse, and can be in communication with the inner conductor 136 to receive the therapy. Thus, the inner conductor 136 can be in electrical communication with the electrode 132 and the ICD 120 to receive the therapy. In this example, the lead 122 can include four electrode assemblies 130, labeled 130 a, 130 b, 130 c, 130 d from the proximal end 124 to the distal end 126 of the lead 122. It should be noted that while the lead 122 is illustrated with four electrode assemblies 130 in FIG. 3, the lead 122 may have any number of electrode assemblies 130.
The proximal end 124 of the lead 122 can include a connector portion 140. As the connector portion 140 can be generally known, the connector portion will not be discussed in great detail herein. Briefly, however, the connector portion 140 can electrically couple the lead 122 to the ICD 120. The distal end 126 can terminate within the anatomical structure adjacent to the desired location for the delivery of the therapy, and generally, for example, can terminate adjacent to an apex of the heart 42, such as the right ventricular apex A, a ventricle, such as the fight ventricle 42 a, or other chambers, such as the right atria 42 b, of the heart 42. As will be discussed, one electrode 132 of the at least one electrode assembly 130 can be coupled to the distal end 126 to deliver a therapy to the atrium A of the heart 42.
The body 128 of the lead 122 can extend from the proximal end 124 to the distal end 126. With reference FIG. 5, the body 128 can include an overlay 142, at least one conductive member or shield 144, and a multilumen member 146. The body 128 can serve to protect, carry and guide the at least one electrode assembly 130 through the anatomical structure. The overlay 142 can comprise any suitable biocompatible material, such as a biocompatible polymer, and can generally be composed of polyurethane. The overlay 142 can be disposed over and coupled to the at least one conductive member 144. For example, the overlay 142 can be formed onto the at least one conductive member 144 such that the overlay 142 is molded onto and penetrates through the at least one conductive member 144 thereby encapsulating the at least one conductive member 144 within the overlay 142 (illustrated in phantom in FIG. 5).
The at least one conductive member 144 can comprise a first conductive braid 144 a and a second conductive braid 144 b. The at least one conductive member 144 can generally extend for a majority of a length of the lead 122, and can generally be electrically coupled to the electrode 132 positioned near a proximal end 124 of the lead 122. It will be understood that although the at least one conductive member 144 is illustrated and described herein as comprising a braid, the at least one conductive member 144 could also comprise any desired shape or structure, such as a coil, continuous tubular structure, etc., and thus, need not be composed of a plurality of interwoven conductive members as shown. The first conductive braid 144 a can extend from the proximal end 124 of the lead 122 to the electrode assembly 130 located near a proximal end of the electrode assembly 130 a. The second conductive braid 144 b can extend from a distal end of the electrode assembly 130 a to a proximal end of a second electrode assembly 130 b. The first conductive braid 144 a and the second conductive braid 144 b can each be in electrical communication with the electrode 132 a of the first electrode assembly 130 a to dissipate a current induced in the first conductive braid 144 a and the second conductive braid 144 b through the electrode 132 a.
The multilumen member 146 can be disposed within the first conductive braid 144 a and the second conductive braid 144 b. The multilumen member 146 can define at least one channel 148 for receipt of each of the inner conductors 136 associated with the electrode assemblies 130. Generally, the multilumen member 146 can be composed of a biocompatible material, such as a biocompatible polymer, for example, a silicone rubber. The at least one channel 148 can receive each of the inner conductors 136 of the electrode assemblies 130, and can serve as a conduit that guides each of the inner conductors 136 from the ICD 120 to the electrode 132 of the respective electrode assembly 130. With reference to FIG. 6, the multilumen member 146 can also include one or more apertures 149 that extend out of a sidewall of the multilumen member 146. The apertures 149 can enable the various electrode assemblies 130 to be electrically coupled to the inner conductors 136 passing through the multilumen member 146.
With reference to FIGS. 3-6, selected ones of the electrode assemblies 130 can be operable to deliver the therapy to the anatomical structure, and a selected one of the electrode assemblies 130 can be operable to sense electrical activity at a desired site in the anatomical structure. The electrode assemblies 130 can include a first electrode or first defibrillator electrode assembly 130 a, a second electrode or second defibrillator electrode assembly 130 b, a sense electrode or ring electrode assembly 130 c and a tip electrode assembly 130 d.
With reference to FIGS. 4-6, the first defibrillator electrode assembly 130 a can be coupled to the body 128 such that the first defibrillator electrode assembly 130 a can be disposed between the proximal end 124 and the distal end 126. The first defibrillator electrode assembly 130 a can include the first defibrillator electrode 132 a and transmission member 134 a. Generally, the first defibrillator electrode assembly 130 a can be coupled to the body 128 such that when the lead 122 is implanted within the anatomical structure, such as the heart 42, the first defibrillator electrode 132 a can be adjacent to a first portion of the anatomical structure, such as the superior vena cava 44 (FIG. 3).
With reference to FIGS. 3 and 6, the first defibrillator electrode 132 a can have a first diameter D1 and a first surface area (generally indicated as A1 in phantom). The first diameter D1 can be substantially equivalent to a diameter D of the overlay 142 so that when the first defibrillator electrode 132 a is coupled to the body 128, a smooth transition exists between the first defibrillator electrode 132 a and the body 128. The first surface area A1 can be larger than a surface area of the electrode 132 d of the distalmost electrode assembly 130 d, generally indicated as SA in phantom. Generally, the first surface area A1 can range from about 400 square millimeters to about 1000 square millimeters, and generally can range from about 750 square millimeters to about 850 square millimeters. As shown in FIG. 6, the first defibrillator electrode 132 a can be coupled to the at least one conductive member 144, the multilumen member 146 of the body 128, and the transmission member 134 a. The transmission member 134 a can pass through one of the channels 148 of the multilumen member 146, and can be in communication with and responsive to the ICD 120 to transmit an electrical signal or charge to the first defibrillator electrode 132 a. The transmission member 134 a can include the inner conductor 136 a that is encased by or coated with an insulative member 138 a, such as a biocompatible polymer, for example, a fluoropolymer.
With reference to FIGS. 4 and 6, the first defibrillator electrode 132 a can be coupled to and in communication with the first conductive braid 144 a and the second conductive braid 144 b (FIG. 6). Generally, the location of the first defibrillator electrode assembly 130 a can be fixed relative to a length of the lead 122 between the proximal end 124 and the distal end 126. The first defibrillator electrode 132 a can be coupled to the first conductive braid 144 a and the second conductive braid 144 b, via any suitable mechanism that enables electrical communication between the first defibrillator electrode 132 a, the first conductive braid 144 a and the second conductive braid 144 b. These mechanisms can include welding, crimping, conductive adhesives, conductive fasteners, etc., as generally indicated by reference numeral 141 in FIG. 6.
Accordingly, if a current is induced in the first conductive braid 144 a and/or second conductive braid 144 b from an external electric field, such as that generated by an MRI, the current and heat generated by the induced current can flow from the first conductive braid 144 a and/or second conductive braid 144 b into the first defibrillator electrode 132 a, which is grounded by the body. With reference to FIG. 3, as the first defibrillator electrode 132 a is adjacent to the anatomical structure, such as the superior vena cava 44, and has a large surface area A1, the current can be dissipated by the first defibrillator electrode 132 a into the anatomical structure. This can ensure that if a current is induced in the first conductive braid 144 a and/or second conductive braid 144 b, any induced current flows to the electrode assembly 130 that has the largest surface area, such as the first defibrillator electrode assembly 130 a. In other words, the at least one outer conductive member or shield 144 shields and prevents currents from being induced in the inner conductors 136 which are surrounded by the at least one outer conductive member or shield 144, thereby preventing induced currents from flowing to a smaller surface electrode assembly 130, such as the tip electrode 132 d.
With reference to FIG. 6, the first defibrillator electrode 132 a can be coupled to the transmission member 134 a disposed in the multilumen member 146 via a connection 150. The connection 150 can couple the first defibrillator electrode 132 a to the inner conductor 136 a to enable electrical communication between the inner conductor 136 a and the first defibrillator electrode 132 a. The connection 150 can include a first end 150 a and a second end 150 b. The first end 150 a can be crimped to the inner conductor 136 a of the transmission member 134 a, while the second end 150 b can be coupled to the first defibrillator electrode 132 a, through welding, for example.
With reference to FIGS. 3 and 4, the second defibrillator electrode assembly 130 b can be coupled to the body 128 such that the second defibrillator electrode assembly 130 b can be disposed near the distal end 126 of the lead 122, between the first electrode assembly 130 a and the ring electrode assembly 130 c. Generally, the location of the second defibrillator electrode assembly 130 b can be fixed relative to the length of the lead 122 between the proximal end 124 and the distal end 126. The second defibrillator electrode assembly 130 b can include the second defibrillator electrode 132 b and the transmission member 134 b. Generally, the second defibrillator electrode assembly 130 a can be coupled to the body 128 such that when the lead 122 is implanted within the anatomical structure, such as the heart 42, the second defibrillator electrode 132 b can be adjacent to a second portion of the anatomical structure, such as a right ventricle 42 a of the heart 42 (FIG. 3).
With reference to FIG. 3, the second defibrillator electrode 132 b can have a second diameter D2 and a second surface area (generally indicated as A2 in phantom). The second diameter D2 can be substantially equivalent to the diameter D of the overlay 142 so that when the second defibrillator electrode 132 b is coupled to the body 128, a smooth transition exists between the second defibrillator electrode 132 b and the body 128. The second surface area A2 can be larger than the surface area SA of the tip electrode assembly 130 d, but can be smaller than the first surface area A1 of the first defibrillator electrode 132 a. Generally, the second surface area A2 can range from about 300 square millimeters to about 800 square millimeters, and generally can range from about 500 square millimeters to about 650 square millimeters.
The second defibrillator electrode 132 b can be adjacent to, but not in electrical communication with the at least one conductive member 144, and can be coupled to the multilumen member 146 of the body 128, and the transmission member 134 b. As the second defibrillator electrode 132 b can be adjacent to, but not in electrical communication with the second conductive braid 144 b, this can ensure that if a current is induced in the second conductive braid 144 b, the current is communicated to the first defibrillator electrode 132 a, which has a larger surface area A1 to dissipate the current, and can dissipate the current in a generally non-critical area of the anatomical structure. The transmission member 134 b can pass through one of the channels 148 of the multilumen member 146, and the inner conductor 136 b can be in communication with and responsive to the ICD 120 to transmit an electrical signal or charge to the second defibrillator electrode 132 b. The inner conductor 136 b can be encased by or coated with the insulative member 138 b, which can comprise a biocompatible polymer, for example a fluoropolymer.
The second defibrillator electrode 132 b can be coupled to the inner conductor 136 b disposed in the multilumen member 146 via a suitable connection, such as the connection 150 (not specifically shown). In this regard, if employed, the connection 150 can electrically couple the second defibrillator electrode 132 b to the inner conductor 136 b. As the connection 150 between the inner conductor 136 b and the second defibrillator electrode 132 b can be substantially similar to that discussed with regard to the first defibrillator electrode assembly 130 a, the connection 150 will not be discussed with regard to the second defibrillator electrode assembly 130 b.
With reference to FIGS. 3 and 4, the sense electrode or ring electrode assembly 130 c can be coupled to the body 128 such that the ring electrode assembly 130 c can be disposed near the distal end 126, between the second electrode assembly 130 b and the tip electrode assembly 130 d. As the ring electrode assembly 130 c can be generally known in the art, and can be similar to the ring electrode assembly of the SPRINT QUATTRO SECURE™ cardiac lead commercially available from Medtronic, Inc. of Minneapolis, Minn., the ring electrode assembly 130 c will not be discussed in great detail herein. Briefly, however, the ring electrode assembly 130 c can include airing electrode 132 c (FIG. 4) and a transmission member 134 c (FIG. 5). The ring electrode 132 c can be adjacent to the anatomical structure, such as the heart 42, to receive electrical signals indicative of the electrical activity of the heart 42. These electrical signals can be transmitted to the ICD 120 via the inner conductor 136 c of the transmission member 134 c. The transmission member 134 c can be disposed in one of the channels 148 of the multilumen member 146.
With reference to FIGS. 3-5, the tip electrode assembly 130 d can extend beyond the multilumen member 146, and can contact the anatomical structure at a distalmost part, such as the right ventricular apex A of the heart 42. As the tip electrode assembly 130 d can be generally known in the art, and can be similar to the tip electrode of the SPRINT QUATTRO SECURE™ cardiac lead commercially available from Medtronic, Inc. of Minneapolis, Minn., the tip electrode assembly 130 d will not be discussed in great detail herein. Briefly, however, the tip electrode assembly 130 d can include a tip electrode 130 d and the transmission member 134 d. The inner conductor 136 d can electrically couple the tip electrode 132 d to the ICD 120 so that the tip electrode 132 d can to receive electrical signals and deliver a therapy, such as a pacing therapy, to the distalmost part of the anatomical structure. As illustrated in FIG. 3, the surface area SA of the tip electrode 132 d can be smaller than the first surface area A1 of the first defibrillator electrode 132 a and the second surface area A2 of the second defibrillator electrode 132 b, and can range from about 1 square millimeter (mm2) to about 8 square millimeters (mm2).
With reference to FIGS. 3-6, in order to assemble the lead 122, in ah exemplary process, the transmission members 134 can be inserted into the multilumen member 146. Then, the connection 150 can be coupled to the respective inner conductors 136 to couple the inner conductors 136 to the respective electrodes 132 (FIG. 6). The first conductive braid 144 a and the second conductive braid 144 b can then be positioned over the multilumen member 146. Next, the overlay 142 can be formed on, applied or extruded onto the first conductive braid 144 a and second conductive braid 144 b. The first conductive braid 144 a and second conductive braid 144 b can then be coupled to the first defibrillator electrode 132 a such that the first conductive braid 144 a and second conductive braid 144 b are in communication with the first defibrillator electrode 132 a. In one embodiment, the outer conductive member 144 can be combined with the overlay 142 in a separate operation, such as a continuous extrusion process or a discrete assembly and heating reflow operation.
With the lead 122 assembled, the lead 122 can be coupled to the ICD 120, and the lead 122 and ICD 120 can be implanted into the anatomical structure. Generally, the lead 122 can be implanted such that the first defibrillator electrode 132 a is adjacent to the superior vena cava 44, the second defibrillator electrode 132 b is within the right ventricle 42 a, and the tip electrode 132 d is adjacent to the right ventricular apex A of the heart 42 (FIG. 3). If the anatomical structure encounters an external field, such as that generated by an MRI, a current may be induced in the at least one outer conductive member 144, which can serve to protect or shield the inner conductors 136 from the induced current, and thereby prevent the transmission of the induced current to an electrode assembly with a small surface area, such as the tip electrode 132 d.
In this regard, as the at least one outer conductive member 144 covers, surrounds or shields the inner conductors 136 of the electrode assemblies 130, the external field generated by the MRI can induce a current in the at least one outer conductive member 144, thereby protecting or shielding the inner conductors 136 from the effects of the external field. Further, as the at least one outer conductive member 144 is in communication with the first defibrillator electrode 132 a, the current and heat induced in the at least one outer conductive member 144 can be dissipated by the first defibrillator electrode 132 a into the anatomical structure, which can serve to as a ground for the at least one outer conductive member 144.
1. An implantable medical device operable to provide a therapy to an anatomical structure comprising:
a therapy device configured to be implanted in a portion of the anatomical structure and operable to generate the therapy for the anatomical structure;
a lead having a proximal end, a distal end and a lead body that includes a first outer conductive braid, a second outer conductive braid and a multilumen member, the first outer conductive braid and the second outer conductive braid disposed about the multilumen member;
a first electrode fixedly coupled between the proximal end and the distal end of the lead such that the first electrode being configured to be positioned adjacent to a first portion of the anatomical structure, the first electrode in communication with the first outer conductive braid and the second outer conductive braid;
a first inner conductor passing through a portion of the multilumen member and in electrical communication with the first electrode and configured to deliver a therapy to the first portion of the anatomical structure;
a tip electrode extending beyond the distal end of the lead;
a tip inner conductor passing through a portion of the multilumen member and in electrical communication with the tip electrode and configured to deliver a therapy to a second portion of the anatomical structure;
a second electrode coupled adjacent to the tip electrode at the distal end of the lead such that the second electrode being configured to be positioned adjacent to a third portion of the anatomical structure;
a second inner conductor passing through a portion of the multilumen member and in electrical communication with the second electrode and configured to deliver a therapy to the third portion of the anatomical structure; and
wherein the first outer conductive braid being disposed between the proximal end of the lead and the first electrode, the second outer conductive braid being disposed between the first electrode and the second electrode, and the first electrode configured to dissipate a current induced in the first outer conductive braid and second outer conductive braid, via the first portion of the anatomical structure.
2. The device of claim 1, wherein the therapy device being an implantable cardioverter-defibrillator (ICD).
a ring electrode coupled adjacent to the tip electrode at the distal end of the lead such that the ring electrode being configured to be positioned adjacent to a fourth portion of the anatomical structure, the ring electrode in communication with a ring inner conductor and configured to transmit a signal indicative of electrical activity at the fourth portion of the anatomical structure.
4. The device of claim 1, wherein the first outer conductive braid and the second outer conductive braid shields the at least one inner conductor from an external field.
5. The device of claim 1, wherein the first outer conductive braid and the second outer conductive braid are coated with a biocompatible polymer.
6. The device of claim 5, wherein the first electrode comprises a first defibrillator electrode, and the second electrode comprises a second defibrillator electrode.
7. The device of claim 6, wherein the first defibrillator electrode and the second defibrillator electrode are electrically coupled to the first inner conductor and the second inner conductor, respectively, in such a manner that the lead has a substantially uniform diameter.
8. The device of claim 1, wherein the first electrode has a first surface area, the second electrode has a second surface area, and the tip electrode has a third surface area, and the first surface area being greater than the second surface area and the third surface area.
US14715271 2008-03-12 2015-05-18 System and method for implantable medical device lead shielding Active 2028-05-23 US9731119B2 (en)
US3595608 true 2008-03-12 2008-03-12
US12112889 US9037263B2 (en) 2008-03-12 2008-04-30 System and method for implantable medical device lead shielding
US14715271 US9731119B2 (en) 2008-03-12 2015-05-18 System and method for implantable medical device lead shielding
US15676279 US20170368335A1 (en) 2008-03-12 2017-08-14 System and method for implantable medical device lead shielding
US12112889 Division US9037263B2 (en) 2008-03-12 2008-04-30 System and method for implantable medical device lead shielding
US15676279 Division US20170368335A1 (en) 2008-03-12 2017-08-14 System and method for implantable medical device lead shielding
US20150246222A1 true US20150246222A1 (en) 2015-09-03
US9731119B2 true US9731119B2 (en) 2017-08-15
ID=41063874
US12112889 Active 2033-02-13 US9037263B2 (en) 2008-03-12 2008-04-30 System and method for implantable medical device lead shielding
US14715271 Active 2028-05-23 US9731119B2 (en) 2008-03-12 2015-05-18 System and method for implantable medical device lead shielding
US15676279 Pending US20170368335A1 (en) 2008-03-12 2017-08-14 System and method for implantable medical device lead shielding
US (3) US9037263B2 (en)
US9084882B1 (en) * 2014-02-26 2015-07-21 Advanced Neuromodulation Systems, Inc. Leads for neurostimulation and methods of assembling same
Citations (362)
US2433480A (en) 1946-05-09 1947-12-30 Richard A Rendich X-ray marker
US2487038A (en) 1944-03-25 1949-11-08 Sonotone Corp Ear insert for earphones
US3788329A (en) 1972-04-17 1974-01-29 Medtronic Inc Body implantable lead
US3842485A (en) 1972-11-01 1974-10-22 Nasa Method of making an explosively welded scarf joint
US4038990A (en) 1975-11-19 1977-08-02 Medtronic, Inc. Cautery protection circuit for a heart pacemaker
US4220813A (en) 1977-09-26 1980-09-02 Medical Components Corp. Terminal for medical instrument
US4280507A (en) 1979-06-27 1981-07-28 Hewlett-Packard Company Patient cable with distributed resistance protection in conductors
US4383225A (en) 1979-07-06 1983-05-10 Ferdy Mayer Cables with high immunity to electro-magnetic pulses (EMP)
US4403824A (en) 1981-03-02 1983-09-13 The Scott & Fetzer Company Plug connector and receptacle
US4852585A (en) 1980-08-08 1989-08-01 Darox Corporation Tin-stannous chloride electrode element
US4947866A (en) 1988-02-16 1990-08-14 Medtronic, Inc. Medical electrical lead
US4951672A (en) 1985-07-02 1990-08-28 General Electric Company Controlled impedance monitoring lead wires
US4991583A (en) 1986-08-13 1991-02-12 Siemens-Pacesetter, Inc. Pacemaker having independently programmable electrode configuration for pacing and sensing and method for operation thereof
US5003992A (en) 1989-08-23 1991-04-02 Holleman Timothy W Atraumatic screw-in lead
US5012045A (en) 1988-03-03 1991-04-30 Sumitomo Electric Industries, Ltd. Cable with an overall shield
US5040544A (en) 1988-02-16 1991-08-20 Medtronic, Inc. Medical electrical lead and method of manufacture
US5260128A (en) 1989-12-11 1993-11-09 Kabushiki Kaisha Riken Electromagnetic shielding sheet
US5265623A (en) 1992-07-16 1993-11-30 Angeion Corporation Optimized field defibrillation catheter
US5314459A (en) 1990-01-23 1994-05-24 Cardiac Pacemakers, Inc. Defibrillation electrode system having smooth current distribution with floating electrode
US5349133A (en) 1992-10-19 1994-09-20 Electronic Development, Inc. Magnetic and electric field shield
EP0617978A2 (en) 1993-03-31 1994-10-05 Medtronic, Inc. Torque indicator for fixed screw leads
US5360441A (en) 1992-10-30 1994-11-01 Medtronic, Inc. Lead with stylet capture member
EP0624383A1 (en) 1993-05-11 1994-11-17 ARIES S.r.l. A neural stimulator
US5374778A (en) 1992-11-02 1994-12-20 Sumitomo Wiring Systems, Ltd. Wire harness
JPH07255863A (en) 1994-03-17 1995-10-09 Kaageo P-Shingu Res Lab:Kk Heart pacemaker
WO1995032673A1 (en) 1994-05-27 1995-12-07 Michelson Gary K Apparatus and method, delivery of electrical current
US5476496A (en) 1993-06-01 1995-12-19 Pacesetter Ab Implantable medical electrode system having an indifferent electrode formed as a part of the electrode insulator sleeve
US5485667A (en) 1994-03-03 1996-01-23 Kleshinski; Stephen J. Method for attaching a marker to a medical instrument
US5504274A (en) 1994-09-20 1996-04-02 United Technologies Corporation Lightweight braided shielding for wiring harnesses
US5514172A (en) 1994-08-31 1996-05-07 Pacesetter, Inc. Multi-conductor lead including a connector with an interlocking insulator
EP0713714A2 (en) 1994-11-22 1996-05-29 Ventritex, Inc. Correlator based electromagnetic interference responsive control system useful in medical devices
WO1996016694A1 (en) 1994-11-30 1996-06-06 Medtronic, Inc. Automatic lead recognition for implantable medical device
US5552565A (en) 1995-03-31 1996-09-03 Hewlett-Packard Company Multiconductor shielded transducer cable
WO1996028951A1 (en) 1995-03-09 1996-09-19 Cochlear Limited Implant device with electrostatic discharge protection
US5571157A (en) 1995-07-19 1996-11-05 Pacesetter, Inc. Endocardial lead with reduced diameter tip portion and method for making such lead
US5594304A (en) 1995-07-31 1997-01-14 Woodhead Industries, Inc. Portable fluorescent lamp for use in special applications
US5606981A (en) 1994-03-11 1997-03-04 C. R. Bard, Inc. Catheter guidewire with radiopaque markers
US5662697A (en) 1995-10-17 1997-09-02 Pacesetter, Inc. Transvenous internal cardiac defibrillation apparatus having lead and electrode providing even distribution of electrical charge
US5683444A (en) 1995-12-11 1997-11-04 Huntley; Steve Composite electrode
WO1997041923A1 (en) 1996-05-03 1997-11-13 Sulzer Intermedics Inc. Implantable cardiac cardioverter/defibrillator with emi suppression filter with independent ground
US5702437A (en) 1996-04-10 1997-12-30 Medtronic Inc. Implantable lead with wires carried by body
US5766232A (en) 1996-05-10 1998-06-16 Medtronic, Inc. Method and apparatus for altering the Q of an implantable medical device telemetry antenna
US5782241A (en) 1993-04-22 1998-07-21 O.D.A.M. Office De Distribution D'appareils Medicaux (Sa) Sensor device for electrocardiogram
WO1998048896A1 (en) 1997-04-25 1998-11-05 Medtronic, Inc. Medical lead connector system
US5842986A (en) 1995-08-16 1998-12-01 Proton Sciences Corp. Ferromagnetic foreign body screening method and apparatus
US5842966A (en) 1990-05-04 1998-12-01 Bio-Magnetic Therapy Systems, Inc. Treatment of arthritis with magnetic field therapy
WO1999010035A2 (en) 1997-08-22 1999-03-04 Image-Guided Neurologics, Inc. Invasive medical device including an opposed solenoid rf coil for mri
JPH1186641A (en) 1997-09-10 1999-03-30 Hitachi Metals Ltd Cable
WO1999019020A1 (en) 1997-10-15 1999-04-22 Minrad Inc. Magnetically compatible peripheral nerve stimulator
EP0920239A2 (en) 1997-11-26 1999-06-02 IMPLEX GmbH Spezialhörgeräte Anchoring means for implantable microphone
US5954760A (en) 1997-05-07 1999-09-21 Pacesetter Ab Helical winding for a cardiac lead
US6033408A (en) 1996-07-30 2000-03-07 Midas Rex, L.P. Resecting tool for magnetic field environment
WO2000027279A1 (en) 1998-11-10 2000-05-18 Durousseau Donald R fMRI COMPATIBLE ELECTRODE AND ELECTRODE PLACEMENT TECHNIQUES
US6103037A (en) 1995-12-12 2000-08-15 Medi-Dyne Inc. Method for making a catheter having overlapping welds
US6152746A (en) 1997-09-12 2000-11-28 Itt Manufacturing Enterprises, Inc. Screened cable terminating ferrule
US6156029A (en) 1997-11-25 2000-12-05 Eclipse Surgical Technologies, Inc. Selective treatment of endocardial/myocardial boundary
US6198807B1 (en) 1999-06-11 2001-03-06 Desena Danforth X-ray labeling tape
US6240322B1 (en) 1998-11-04 2001-05-29 Cardiac Pacemakers, Inc. System and apparatus having low profile collapsible tines
US6258071B1 (en) 1995-08-31 2001-07-10 Jocelyn Asher Simon Brookes Magnetic resonance-compatible needle
US6269148B1 (en) 1998-11-09 2001-07-31 The Suremark Company Radiographic image marking system
US6284971B1 (en) 1998-11-25 2001-09-04 Johns Hopkins University School Of Medicine Enhanced safety coaxial cables
US6302740B1 (en) 1996-04-18 2001-10-16 Interconnect Ab Shielded cable and connector assembly
WO2001080940A1 (en) 2000-04-20 2001-11-01 Greatbio Technologies, Inc. Mri-resistant implantable device
US20010044646A1 (en) 2000-02-22 2001-11-22 Medtronic, Inc. Extractable implantable medical lead
WO2002000292A1 (en) 2000-06-27 2002-01-03 Neopraxis Pty Ltd Stretchable conducting lead
US20020058978A1 (en) 1999-10-08 2002-05-16 Sass Richard G. Cardiac implant cable having a coaxial lead
US20020082673A1 (en) 2000-12-21 2002-06-27 Benz Michael E. Polymeric materials with improved dielectric breakdown strength
US20020106918A1 (en) 2001-01-17 2002-08-08 Yazaki Corporation Terminal end structure for shielded wire
US20020111659A1 (en) 2001-02-09 2002-08-15 Davis Scott J. Implantable therapy delivery element adjustable anchor
US20020111663A1 (en) 2000-12-29 2002-08-15 Roger Dahl System for providing electrical stimulation to a left chamber of a heart
WO2002083236A2 (en) 2001-03-19 2002-10-24 Medtronic, Inc. Control of externally induced current in an implantable pulse generator
US6471699B1 (en) 1993-10-14 2002-10-29 Ep Technologies, Inc. Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements
US6488704B1 (en) 2001-05-07 2002-12-03 Biomed Solutions, Llc Implantable particle measuring apparatus
US20020183822A1 (en) 2001-05-30 2002-12-05 Bodner Jeffrey P. Extendable/retractable lead having downsized lead body
US20020183438A1 (en) 2001-04-27 2002-12-05 Jayantha Amarasekera Conductive plastic compositions and method of manufacture thereof
US6494916B1 (en) 2001-07-30 2002-12-17 Biomed Solutions, Llc Apparatus for replacing musculo-skeletal parts
US6503648B1 (en) 2001-03-26 2003-01-07 Biomed Solutions, Llc Implantable fuel cell
EP1273922A1 (en) 2001-07-06 2003-01-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Methods and devices for measuring electrical currents
US20030009207A1 (en) 2001-07-09 2003-01-09 Paspa Paul M. Implantable medical lead
US20030014080A1 (en) 2001-06-28 2003-01-16 Baudino Michael D. Low impedance implantable extension for a neurological electrical stimulator
US20030044623A1 (en) 2001-05-07 2003-03-06 Ikuo Sakurai Electromagnetic wave absorber
US20030045920A1 (en) 2000-10-17 2003-03-06 Medtronic, Inc. Radiopaque marking of lead electrode zone in a continuous conductor construction
US6538191B1 (en) 2001-09-26 2003-03-25 Biomed Solutions, Llc Photocell with fluorescent conversion layer
US20030083570A1 (en) 2001-10-31 2003-05-01 Cho Yong Kyun Alternative sensing method for implantable medical device in magnetic resonance imaging device
US20030093107A1 (en) 2001-09-28 2003-05-15 Edward Parsonage Medical devices comprising nanocomposites
US20030109901A1 (en) 2001-12-11 2003-06-12 Wilson Greatbatch Photonic pacemaker-cardiac monitor
US6583361B2 (en) 2000-05-25 2003-06-24 Nexans Flexible coaxial cable and a method of manufacturing it
US20030120197A1 (en) 2001-05-28 2003-06-26 Takashi Kaneko Composite material for medical applications, tube for medical applications and medical instrument
US20030117787A1 (en) 2001-10-17 2003-06-26 Laird Technologies, Inc. Method and apparatus for EMI shielding
US20030139806A1 (en) 2001-06-11 2003-07-24 Scimed Life Systems, Inc. Composite ePTFE/textile prosthesis
US20030144716A1 (en) 2002-01-29 2003-07-31 Reinke James D. Method and apparatus for shunting induced currents in an electrical lead
WO2003061755A2 (en) 2002-01-22 2003-07-31 Nanoset, Llc Nanomagnetically shielded substrate
US20030144717A1 (en) 2002-01-28 2003-07-31 Hagele Richard J. Ceramic cardiac electrodes
US20030140931A1 (en) 2002-01-29 2003-07-31 Zeijlemaker Volkert A. Medical implantable system for reducing magnetic resonance effects
US20030144704A1 (en) 2002-01-29 2003-07-31 Terry Michael B. Method and apparatus for detecting static magnetic fields
US20030144705A1 (en) 2002-01-29 2003-07-31 Medtronic, Inc. Methods and apparatus for controlling a pacing system in the presence of EMI
WO2003063954A1 (en) 2002-01-29 2003-08-07 Medtronic, Inc. Conditioning of coupled electromagnetic signals on a lead
US20030167052A1 (en) 1999-12-29 2003-09-04 Lee Jeong S. Catheter assemblies with flexible radiopaque marker
WO2003075797A2 (en) 2002-03-14 2003-09-18 Angiomed Gmbh & Co. Medizintechnik Kg Mri compatible stent and method of manufacturing the same_______
US20030225331A1 (en) 2002-01-23 2003-12-04 The Regents Of The University Of California Implantable thermal treatment method and apparatus
US20040024442A1 (en) 2002-06-25 2004-02-05 Scimed Life Systems, Inc. Elastomerically impregnated ePTFE to enhance stretch and recovery properties for vascular grafts and coverings
US20040020674A1 (en) 2002-06-14 2004-02-05 Laird Technologies, Inc. Composite EMI shield
US20040028859A1 (en) 1998-09-11 2004-02-12 Legrande Wayne B. Electrically conductive and electromagnetic radiation absorptive coating compositions and the like
WO2004012809A1 (en) 2002-08-06 2004-02-12 Neopraxis Pty Ltd A method and system for inserting an electrode
US6695761B2 (en) 2002-01-30 2004-02-24 Biomed Solutions, Llc Apparatus for assisting a heart
US6708051B1 (en) 1998-11-10 2004-03-16 Compumedics Limited FMRI compatible electrode and electrode placement techniques
US6713671B1 (en) 2002-01-22 2004-03-30 Nanoset, Llc Magnetically shielded assembly
US20040071949A1 (en) 2001-07-27 2004-04-15 Glatkowski Paul J. Conformal coatings comprising carbon nanotubes
US6743055B1 (en) 1998-08-24 2004-06-01 Cardiac Pacemakers, Inc. Adapter integrated into a lead body
EP1424095A1 (en) 2002-11-26 2004-06-02 Wilson Greatbatch Technologies, Inc. Nanotube coatings for implantable electrodes
US20040106958A1 (en) 2001-02-13 2004-06-03 Quetzal Biomedical Inc. Multi-electrode apparatus and method for treatment of congestive heart failure
US6750055B1 (en) 2001-03-07 2004-06-15 Biomed Solutions Llc Implantable artificial organ and physiological monitoring system
WO2004052448A1 (en) 2002-12-09 2004-06-24 Northstar Neuroscience, Inc. System and method for treating parkinson's disease and other movement disorders
US6768053B1 (en) 2002-01-09 2004-07-27 Nanoset, Llc Optical fiber assembly
US20040162600A1 (en) 2003-02-14 2004-08-19 Medtronic, Inc. Reverse wound electrodes
WO2004073040A2 (en) 2003-02-13 2004-08-26 Medtronic, Inc. Esd protection circuit
US20040167443A1 (en) 2003-02-26 2004-08-26 Scimed Life Systems, Inc. Elongated intracorporal medical device
US20040173368A1 (en) 2003-03-07 2004-09-09 Hewlett-Packard Development Company, L.P. Lossy coating for reducing electromagnetic emissions
US6793642B2 (en) 2001-05-07 2004-09-21 Biomed Solutions, Llc Flow cytometer
EP1466576A1 (en) 2003-04-11 2004-10-13 Chen, Yi-Ying Method and apparatus for using a varying frequency signal to stimulate the human body
US20040220549A1 (en) 2003-04-14 2004-11-04 Dittman Jay A. Large diameter delivery catheter/sheath
US20040267328A1 (en) 2003-06-24 2004-12-30 Medtronic, Inc. Electrode selection system for medical electrical leads
US20050065587A1 (en) 2003-09-24 2005-03-24 Mark Gryzwa Implantable lead with magnetic jacket
US6872882B2 (en) 2001-07-16 2005-03-29 W.E.T. Automotive Systems Ag Areal electric conductor comprising a constriction
US20050080471A1 (en) 2003-08-28 2005-04-14 Yougandh Chitre Lead body construction
WO2005032654A1 (en) 2003-09-30 2005-04-14 Medtronic, Inc. Field steerable electrical stimulation paddle, lead system, and medical device incorporating the same
US6882519B2 (en) 2003-03-31 2005-04-19 Rubycon Corporation Flat aluminum electrolytic capacitor and method of manufacturing the same
US20050115624A1 (en) 2003-12-02 2005-06-02 Walak Steven E. Composite medical device and method of forming
US20050137664A1 (en) 2003-12-18 2005-06-23 Medtronic, Inc. Suture sleeve
WO2005102447A1 (en) 2004-03-30 2005-11-03 Medtronic, Inc. Mri-safe implantable lead
US6968235B2 (en) 2001-07-17 2005-11-22 Medtronic, Inc. Enhanced method and apparatus to identify and connect a small diameter lead with a low profile lead connector
US6980865B1 (en) 2002-01-22 2005-12-27 Nanoset, Llc Implantable shielded medical device
US20060030918A1 (en) 2004-08-04 2006-02-09 Chinn Kenny K Operating room lead connector
EP1625875A1 (en) 2004-08-09 2006-02-15 Advanced Neuromodulation Systems, Inc. System and method for providing strain relief for medical device leads
US20060036306A1 (en) 2004-08-13 2006-02-16 Heist E K Telescoping, dual-site pacing lead
EP1632265A1 (en) 2004-09-02 2006-03-08 Greatbatch-Sierra, Inc. Apparatus and process for reducing the susceptibility of active implantable medical devices to medical procedures such as magnetic resonance imaging
US7015392B1 (en) 2003-05-28 2006-03-21 Accellent, Inc. High torsional ductility wire and methods of making the same
WO2006031317A2 (en) 2004-08-09 2006-03-23 The Johns Hopkins University Implantable mri compatible stimulation leads and antennas and related systems and methods
US20060079926A1 (en) 2004-10-07 2006-04-13 Rupesh Desai Vasoocclusive coil with biplex windings to improve mechanical properties
US20060089680A1 (en) 2004-10-27 2006-04-27 Bruchmann Richard A Welded connector attachment
US20060095078A1 (en) 2004-10-29 2006-05-04 Tronnes Carole A Expandable fixation mechanism
US7058192B2 (en) 2000-12-14 2006-06-06 Phonak Ag Fixation element for an implantable microphone
US20060135962A1 (en) 2004-09-09 2006-06-22 Kick George F Expandable trans-septal sheath
US7076302B2 (en) 2002-10-10 2006-07-11 Cardiac Pacemakers, Inc. Connection verification apparatus, systems, and methods
US20060155270A1 (en) 2002-11-27 2006-07-13 Hancock Christopher P Tissue ablation apparatus and method of ablating tissue
US20060167527A1 (en) 2001-11-13 2006-07-27 Femano Philip A Apparatus and method for repair of spinal cord injury
US20060167522A1 (en) 2005-01-25 2006-07-27 Malinowski Zdzislaw B Connector for use in an implantable stimulator device
US7103413B2 (en) 2002-07-12 2006-09-05 Cardiac Pacemakers, Inc. Ferrite core telemetry coil for implantable medical device
US20060200218A1 (en) 2005-02-01 2006-09-07 Wahlstrand Carl D Extensible implantable medical lead
US7113827B2 (en) 2003-01-17 2006-09-26 Ela Medical S.A.S. Determining the presence and type of probe associated with an active implantable medical device, in particular a cardiac pacemaker
US20060224207A1 (en) 2005-03-31 2006-10-05 Dublin Garry L Optional telemetry antenna for implantable medical devices
US20070021811A1 (en) 2005-07-19 2007-01-25 Cardiac Pacemakers, Inc. Medical device including radiopaque polymer coated coil and method therefor
GB2429154A (en) 2005-07-13 2007-02-21 Sull Ltd Sleeve for securing a line to a patient
US20070106332A1 (en) 2005-11-04 2007-05-10 Stephen Denker MRI Compatible Implanted Electronic Medical Device
US20070129779A1 (en) 2004-02-04 2007-06-07 Ayre Peter J Percutaneous lead
US7233825B2 (en) 2003-02-15 2007-06-19 Medtronic, Inc. Impedance measurement in implanted device
US20070185556A1 (en) 2002-04-11 2007-08-09 Williams Terrell M Medical electrical lead body designs incorporating energy dissipating shunt
US20070208383A1 (en) 2002-04-11 2007-09-06 Williams Terrell M Medical electrical lead body designs incorporating energy dissipating shunt
US7286882B2 (en) 2003-10-03 2007-10-23 Medtronic, Inc. Implantable electrical connector system
US7286871B2 (en) 2000-08-15 2007-10-23 The Regents Of The University Of California Method and apparatus for reducing contamination of an electrical signal
WO2007124273A1 (en) 2006-04-24 2007-11-01 Medtronic, Inc. Implanted medical device detection
WO2007126657A1 (en) 2006-03-29 2007-11-08 Rita Medical Systems, Inc. An implantable cathether and method of using same
US7294785B2 (en) 2003-06-19 2007-11-13 Ge Healthcare Finland Oy Patient cable for medical measurements
WO2007149757A2 (en) 2006-06-23 2007-12-27 Medtronic, Inc Electrode system with shunt electrode
US20080033497A1 (en) 2005-11-04 2008-02-07 Cherik Bulkes Mri compatible implanted electronic medical device and lead
US20080058715A1 (en) 2001-11-08 2008-03-06 Houser Russell A Rapid Exchange Catheter with Stent Deployment, Therapeutic Infusion, and Lesion Sampling Features
EP1935449A1 (en) 2006-12-19 2008-06-25 Quan Emerteq Corporation Braided electrical lead
US20080154326A1 (en) 2006-12-21 2008-06-26 Clyne Christopher A Method and apparatus for providing a radiopaque anchoring sleeve
WO2008088568A1 (en) 2007-01-18 2008-07-24 Medtronic, Inc. Hermetic lead connector assembly
US20080183263A1 (en) 2007-01-26 2008-07-31 Medtronic, Inc. Lead having reinforcing member
US20080195186A1 (en) 2007-02-14 2008-08-14 Bernard Li Continuous conductive materials for electromagnetic shielding
US20080195187A1 (en) 2007-02-14 2008-08-14 Bernard Li Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
US20080215008A1 (en) 2006-12-20 2008-09-04 Nance Edward J Expandable trans-septal sheath
WO2008111986A1 (en) 2007-03-09 2008-09-18 Medtronic, Inc. Medical device electrical lead design for preventing transmittance of unsafe currents to a patient
US20080242944A1 (en) 2007-03-30 2008-10-02 General Electric Company Method and system for facilitating error free scan administration
US20080243081A1 (en) 2007-03-30 2008-10-02 Onset Medical, Inc. Expandable trans-septal sheath
US20080262582A1 (en) 2007-04-20 2008-10-23 Medtronic, Inc. Implantable medical electrical lead and connector assembly
US20080269863A1 (en) 2007-04-25 2008-10-30 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
WO2008140376A1 (en) 2007-05-14 2008-11-20 St. Jude Medical Ab Tantalum electrode
US20080287804A1 (en) 2006-11-07 2008-11-20 Henry Nita Ultrasound catheter having improved distal end
WO2009011440A1 (en) 2007-07-13 2009-01-22 Seiren Co., Ltd. Double knitted fabric excellent in prevention of run or curling and method of processing the same
US20090234402A1 (en) 2008-03-12 2009-09-17 Marshall Mark T System and method for cardiac lead shielding
US20090240235A1 (en) 2004-12-09 2009-09-24 Kaneka Corporation Medical catheter tube and process for producing the same
US20090259272A1 (en) 2008-04-15 2009-10-15 Reddy G Shantanu Bundle of his stimulation system
WO2009134901A1 (en) 2008-04-30 2009-11-05 Medtronic, Inc. Magnetic resonance imaging shunt electrodes with self-healing coatings
US7674972B2 (en) 2007-11-21 2010-03-09 Delphi Technologies, Inc. Fold-in braided shield
US20100069743A1 (en) 2005-03-04 2010-03-18 C. R. Bard, Inc. Systems and methods for identifying an access port
WO2010062988A2 (en) 2008-11-26 2010-06-03 Medtronic, Inc. Patient programmer with automated mri compatibility verification for active implantable medical device
US20100137957A1 (en) 2007-04-27 2010-06-03 St. Jude Medical Ab Medical implantable lead
US20100198327A1 (en) 2009-02-04 2010-08-05 Pacesetter, Inc. Active Fixation Implantable Medical Lead Configured to Indicate via Fluoroscopy Embedment of Helical Anchor in Cardiac Tissue
US20100256528A1 (en) 2009-04-03 2010-10-07 Scientia Vascular, Llc Micro-fabricated Guidewire Devices Having Varying Diameters
US20100256604A1 (en) 2009-04-03 2010-10-07 Scientia Vascular, Llc Micro-fabricated Catheter Devices Formed Having Elastomeric Compositions
US20100268310A1 (en) 2006-04-28 2010-10-21 Medtronic, Inc. Implantable medical electrical stimulation lead, such as pne lead, and method of use
US7822484B1 (en) 2007-04-03 2010-10-26 Pacesetter, Inc. MRI-compatible implantable lead having high impedance electrodes
WO2010126871A2 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Termination of a shield within an implantable medical lead
WO2010126935A2 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Verification that a patient with an implantable medical system can undergo a magnetic resonance imaging scan
WO2010135440A1 (en) 2009-05-22 2010-11-25 Medtronic, Inc. A cover having self-anchoring protrusions for use with an implantable medical device
US20100331938A1 (en) 2009-06-30 2010-12-30 Medtronic, Inc. Implantable medical device lead
US20110015713A1 (en) 2008-10-23 2011-01-20 Pacesetter, Inc. Systems and methods for reducing lead heating and the risks of mri-induced stimulation
US20110034983A1 (en) 2009-08-07 2011-02-10 Pacesetter, Inc. Implantable medical device lead incorporating a conductive sheath surrounding insulated coils to reduce lead heating during mri
US7933652B2 (en) 2007-01-18 2011-04-26 Medtronic, Inc. Bi-directional connector assembly for an implantable medical device
US8007440B2 (en) 2005-02-08 2011-08-30 Volcano Corporation Apparatus and methods for low-cost intravascular ultrasound imaging and for crossing severe vascular occlusions
US20110230943A1 (en) 2010-03-17 2011-09-22 Greatbatch Ltd. Implantable lead for an active medical device having an inductor design minimizing eddy current losses
US20110319905A1 (en) 2010-06-23 2011-12-29 Palme Robert A Multiple function vascular device
US8106657B2 (en) 2005-07-05 2012-01-31 Commissariat A L'energie Atomique Apparatus for high-resolution NMR spectroscopy and/or imaging with an improved filling factor and RF field amplitude
US20120041528A1 (en) 2009-04-30 2012-02-16 Medtronic, Inc Termination of a shield within an implantable medical lead
WO2012103419A2 (en) 2011-01-28 2012-08-02 Medtronic, Inc. Implantable medical leads and systems that utilize reflection points to control induced radio frequency energy
WO2013158189A1 (en) 2012-04-19 2013-10-24 Medtronic, Inc. Paired medical lead bodies with braided conductive shields having different physical parameter values
US20150170792A1 (en) 2013-12-14 2015-06-18 Medtronic, Inc. Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead
Patent Citations (548)
US5456705A (en) 1993-03-31 1995-10-10 Medtronic, Inc. Medical electrical lead having a torque indicator
US5473812A (en) 1993-03-31 1995-12-12 Medtronic, Inc. Method of manufacturing medical electrical lead having a torque indicator
EP0760196A1 (en) 1995-03-09 1997-03-05 Cochlear Limited Implant device with electrostatic discharge protection
US5897584A (en) 1996-10-22 1999-04-27 Medtronic, Inc. Torque transfer device for temporary transvenous endocardial lead
US7282260B2 (en) 1998-09-11 2007-10-16 Unitech, Llc Electrically conductive and electromagnetic radiation absorptive coating compositions and the like
US6792316B2 (en) 1999-10-08 2004-09-14 Advanced Neuromodulation Systems, Inc. Cardiac implant cable having a coaxial lead
US20020038135A1 (en) 2000-04-20 2002-03-28 Connelly Patrick R. MRI-resistant implantable device
US20070293924A1 (en) 2000-10-17 2007-12-20 Belden Elisabeth L Radiopaque marking of lead electrode zone in a continuous conductor construction
US6648690B2 (en) 2001-01-17 2003-11-18 Yazaki Corporation Terminal end structure for shielded wire
US20020138107A1 (en) 2001-02-20 2002-09-26 Weiner Michael L. Electromagnetic interference immune tissue invasive system
US20020138108A1 (en) 2001-02-20 2002-09-26 Weiner Michael L. Electromagnetic interference immune tissue invasive system
US20020138102A1 (en) 2001-02-20 2002-09-26 Weiner Michael L. Electromagnetic interference immune tissue invasive system
US20020138110A1 (en) 2001-02-20 2002-09-26 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US20020138112A1 (en) 2001-02-20 2002-09-26 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US20020133202A1 (en) 2001-02-20 2002-09-19 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US20020133200A1 (en) 2001-02-20 2002-09-19 Weiner Michael L. Electromagnetic interference immune tissue invasive system
US20020133208A1 (en) 2001-02-20 2002-09-19 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US20020133086A1 (en) 2001-02-20 2002-09-19 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US20020133211A1 (en) 2001-02-20 2002-09-19 Weiner Michael L. Electromagnetic interference immune tissue invasive system
US20020133216A1 (en) 2001-02-20 2002-09-19 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US20020133201A1 (en) 2001-02-20 2002-09-19 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US20020133199A1 (en) 2001-02-20 2002-09-19 Macdonald Stuart G. Electromagnetic interference immune tissue invasive system
US20020128689A1 (en) 2001-02-20 2002-09-12 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US20020128691A1 (en) 2001-02-20 2002-09-12 Connelly Patrick R. Electromagnetic interference immune tissue invasive system
US6689835B2 (en) 2001-04-27 2004-02-10 General Electric Company Conductive plastic compositions and method of manufacture thereof
US6869683B2 (en) 2001-05-07 2005-03-22 Shin-Etsu Chemical Co., Ltd. Electromagnetic wave absorber
US7118693B2 (en) 2001-07-27 2006-10-10 Eikos, Inc. Conformal coatings comprising carbon nanotubes
US7076283B2 (en) 2001-10-31 2006-07-11 Medtronic, Inc. Device for sensing cardiac activity in an implantable medical device in the presence of magnetic resonance imaging interference
WO2003037429A1 (en) 2001-10-31 2003-05-08 Medtronic,Inc. Alternative sensing method for implantable medical device in magnetic resonance imaging device
US6845259B2 (en) 2001-12-26 2005-01-18 Advanced Cardiovascular Systems, Inc. MRI compatible guide wire
US6930242B1 (en) 2002-01-22 2005-08-16 Nanoset, Llc Magnetically shielded conductor
US20050182471A1 (en) 2002-01-22 2005-08-18 Xingwu Wang Magnetically shielded conductor
WO2003063952A2 (en) 2002-01-29 2003-08-07 Medtronic,Inc. Method and apparatus for shielding against mri disturbances
WO2003063955A1 (en) 2002-01-29 2003-08-07 Medtronic, Inc. Electromagnetic trap for a lead
US6937906B2 (en) 2002-01-29 2005-08-30 Medtronic, Inc. Method and apparatus for detecting static magnetic fields
WO2003063956A2 (en) 2002-01-29 2003-08-07 Medtronic,Inc. Medical implantable system for reducing magnetic resonance effects
WO2003063953A2 (en) 2002-01-29 2003-08-07 Medtronic,Inc. Method and apparatus for shunting induced currents in an electrical lead
WO2003063957A2 (en) 2002-01-29 2003-08-07 Medtronic, Inc. Method and apparatus for shielding wire for mri resistant electrode systems
WO2003063948A2 (en) 2002-01-29 2003-08-07 Medtronic,Inc. Method and apparatus for detecting static magnetic fields
WO2003063946A2 (en) 2002-01-29 2003-08-07 Medtronic,Inc. Apparatus and method for shunting induced currents in an electrical lead
WO2003095022A2 (en) 2002-05-10 2003-11-20 Medtronic, Inc. Methods and apparatus for controlling a pacing system in the presence of emi
US20050145307A1 (en) 2003-02-26 2005-07-07 Shireman Brice L. Elongated intracorporal medical device
US20070123805A1 (en) 2003-02-26 2007-05-31 Boston Scientific Scimed, Inc. Elongated intracorporal medical device
US6982378B2 (en) 2003-03-07 2006-01-03 Hewlett-Packard Development Company, L.P. Lossy coating for reducing electromagnetic emissions
US7738942B2 (en) 2003-04-02 2010-06-15 Medtronic, Inc. Device and method for preventing magnetic-resonance imaging induced damage
US20040251042A1 (en) 2003-04-02 2004-12-16 Biophan Technologies, Inc. Device and method for preventing magnetic-resonance imaging induced damage
US7123013B2 (en) 2003-06-24 2006-10-17 Biophan Technologies, Inc. Magnetic resonance imaging interference immune device
WO2005030322A1 (en) 2003-09-26 2005-04-07 Medtronic, Inc. Energy shunt for producing an mri-safe implantable medical device
US7082337B2 (en) 2003-12-18 2006-07-25 Medtronic, Inc. Suture sleeve
US8676340B2 (en) 2004-03-30 2014-03-18 Medtronic, Inc. MRI-safe implantable lead
WO2005102445A1 (en) 2004-03-30 2005-11-03 Medtronic, Inc. Lead electrode for use in an mri-safe implantable medical device
WO2005102444A2 (en) 2004-03-30 2005-11-03 Medtronic, Inc. Mri-safe implantable medical device
US20110071604A1 (en) 2004-03-30 2011-03-24 Wahlstrand Carl D MRI-Safe Implantable Lead
US20140200643A1 (en) 2004-03-30 2014-07-17 Medtronic, Inc. MRI-Safe Implantable Lead
WO2005102446A1 (en) 2004-03-30 2005-11-03 Medtronic, Inc. Lead electrode for use in an mri-safe implantable medical device
US20110112615A1 (en) 2004-03-30 2011-05-12 Thomas Barry Hoegh Lead Electrode for Use in an MRI-Safe Implantable Medical Device
US20110071605A1 (en) 2004-03-30 2011-03-24 Wahlstrand Carl D MRI-Safe Implantable Medical Device
US20080039709A1 (en) 2004-08-09 2008-02-14 Karmarkar Parag V Implantable Mri compatible Stimulation Leads And Antennas And Related Systems And Methods
US20120330383A1 (en) 2005-02-01 2012-12-27 Wahlstrand Carl D Extensible Implantable Medical Lead
US20110251487A1 (en) 2005-02-08 2011-10-13 Volcano Corporation Apparatus and Methods for Intravascular Ultrasound Imaging and for Crossing Severe Vascular Occlusions
WO2006093685A1 (en) 2005-02-25 2006-09-08 Medtronic, Inc. Lead electrode for use in an mri-safe implantable medical device
WO2006093686A2 (en) 2005-03-02 2006-09-08 Medtronic, Inc. Lead electrode for use in an mri-safe implantable medical device
US7319901B2 (en) 2005-03-31 2008-01-15 Medtronic, Inc. Optional telemetry antenna for implantable medical devices
WO2006118640A1 (en) 2005-04-29 2006-11-09 Medtronic, Inc. Lead electrode for use in an mri-safe implantable medical device
US20110071599A1 (en) 2005-04-29 2011-03-24 Olsen James M Lead electrode for use in an mri-safe implantable medical device
US20120010689A1 (en) 2005-04-29 2012-01-12 Medtronic, Inc. Lead electrode for use in an mri-safe implantable medical device
WO2006118641A1 (en) 2005-04-29 2006-11-09 Medtronic, Inc. Lead electrode for use in an mri-safe implantable medical device
US20090221970A1 (en) 2005-07-13 2009-09-03 Marc Howard Spinoza Method and apparatus for securing a line to a patient
WO2008100839A1 (en) 2007-02-14 2008-08-21 Medtronic, Inc. Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
WO2008100840A1 (en) 2007-02-14 2008-08-21 Medtronic, Inc. Continuous conductive materials for electromagnetic shielding
US20100145426A1 (en) 2007-03-09 2010-06-10 Medtronic, Inc. Medical device electrical lead design for preventing transmittance of unsafe currents to a patient
US7711436B2 (en) 2007-03-09 2010-05-04 Medtronic, Inc. Medical device electrical lead design for preventing transmittance of unsafe currents to a patient
WO2008130409A1 (en) 2007-04-20 2008-10-30 Medtronic, Inc. Implantable medical electrical lead and connector assembly
US8620455B2 (en) 2007-04-25 2013-12-31 Medtronic, Inc Lead or lead extension having a conductive body and conductive body contact
US20140288626A1 (en) 2007-04-25 2014-09-25 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US8744598B2 (en) 2007-04-25 2014-06-03 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US20130296991A1 (en) 2007-04-25 2013-11-07 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
WO2008134196A1 (en) 2007-04-25 2008-11-06 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US20140107746A1 (en) 2007-04-25 2014-04-17 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US8170691B2 (en) 2007-04-27 2012-05-01 St. Jude Medical Ab Medical implantable lead
US20120035694A1 (en) 2009-04-30 2012-02-09 Medtronic, Inc. Grounding of a shield within an implantable medical lead
US20120035951A1 (en) 2009-04-30 2012-02-09 Medtronic, Inc. Verification that a patient with an implantable medical system can undergo a magnetic resonance imaging scan
US20120035616A1 (en) 2009-04-30 2012-02-09 Medtronic, Inc. Steering an implantable medical lead via a rotational coupling to a stylet
US20120041529A1 (en) 2009-04-30 2012-02-16 Medtronic Inc. Establishing continuity between a shield within an implantable medical lead and a shield within an implantable lead extension
US20120046722A1 (en) 2009-04-30 2012-02-23 Medtronic, Inc. Shielding an implantable medical lead
US20120053664A1 (en) 2009-04-30 2012-03-01 Michael Hegland shielded implantable medical lead with reduced torsional stiffness
WO2010126887A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Termination of a shield within an implantable medical lead
US20120130461A1 (en) 2009-04-30 2012-05-24 Medtronic, Inc. Radiopaque markers for implantable medical leads, devices, and systems
US20150082618A1 (en) 2009-04-30 2015-03-26 Medtronic, Inc. Shielded implantable medical lead with reduced torsional stiffness
US8903504B2 (en) 2009-04-30 2014-12-02 Medtronic Inc. Shielded implantable medical lead with reduced torsional stiffness
US20140345132A1 (en) 2009-04-30 2014-11-27 Medtronic, Inc. Termination of a shield within an implantable medical lead
WO2010126884A2 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Grounding of a shield within an implantable medical lead
WO2011019416A1 (en) 2009-04-30 2011-02-17 Medtronic, Inc. A shielded implantable medical lead with reduced torsional stiffness
US20140350654A1 (en) 2009-04-30 2014-11-27 Medtronic, Inc. Grounding of a shield within an implantable medical lead
US20120035697A1 (en) 2009-04-30 2012-02-09 Stone Richard T Shielded implantable medical lead with guarded termination
WO2010126943A2 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Grounding of a shield within an implantable medical lead
WO2010126946A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Establishing continuity between a shield within an implantable medical lead and a shield within an implantable lead extension
WO2010126877A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Shielding an implantable medical lead
WO2010126939A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. A shielded implantable medical lead with guarded termination
WO2010126975A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. A shielded implantable medical lead with reduced torsional stiffness
WO2010126949A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Radiopaque markers for implantable medical leads, devices and systems
US20120035695A1 (en) 2009-04-30 2012-02-09 Olsen James M Grounding of a shield within an implantable medical lead
US20120059467A1 (en) 2009-05-22 2012-03-08 Michael Hexiang Zhu Drew cover having self-anchoring protrusions for use with an implantable medical device
Baker et al., "Evaluation of Specific Absorption Rates as a Dosimeter of MRI-Related Implant Heating", Journal of Magnetic Resonance Imaging 20:315-320 (2004).
Baker, K., et al., "Neurostimulation Systems: Assessment of Magnetic Field Interactions Associated with 1.5 and 3-Tesla MR Systems", J. Magn. Reson. Imaging, Jan. 2005, 21(1);72-7.
Chung, D.D.L., "Carbon Fiber Composites", 1994, chapter 1, p. 8, table 1.2, Elsevier, ISBN: 978-0-7506-9169-7.
Chung, D.D.L., Comparison of Submicron-Diameter Carbon Filaments and Conventional Carbon Fibers as Fillers in Composite Materials, Carbon 39 (2001) pp. 1119-1125, Elsevier Science Ltd.
Chung, D.D.L., Electromagnetic Interference Shielding Effectiveness of Carbon Materials, Carbon 29 (2001) pp. 279-285, Elsevier Science Ltd.
Engdahl, Tomi, "Ground Loop Basics." Web Jan. 4, 2009, ePanorama.net www.epanorama.net/documents/groundloop/basics.html 28052.00 U.S. Appl. No. 11/739,787.
Finelli, D., et al., "MRI Imaging-Related Heating of Deep Brain Stimulation Electrodes: in Vitro Study", AJNR Am. J. Neuroadiol 23:1, Nov./Dec. 2002.
Jou, W.S. "A Novel Structure of Woven Continuous-Carbon Fiber Composites with High Electromagnetic Shielding", Journal of Electronic Materials, vol. 33, No. 3, Mar. 1, 2004, pp. 162-170(9), Minerals, Metals and Materials Society, http://findarticles.com/p/articles/mi-qu3776/is-200403/ai-n9405-582/print.
Jou, W.S. "A Novel Structure of Woven Continuous-Carbon Fiber Composites with High Electromagnetic Shielding", Journal of Electronic Materials, vol. 33, No. 3, Mar. 1, 2004, pp. 162-170(9), Minerals, Metals and Materials Society, http://findarticles.com/p/articles/mi—qu3776/is—200403/ai—n9405—582/print.
Kolin, et al., "An Electromagnetic Catheter Flow Meter for Determination of Blood Flow in Major Arteries," Department of Biophysics, Physiology, and Radiology, University of California School of Medicine (Los Angeles) Jan. 19, 1988, Proc. N.A.S. vol. 59, pp. 808-815.
Kolin, et al., "An Electromagnetic Intravascular Blood-Flow Sensor", Department of Biophysics, University of California School of Medicine (Los Angeles), Mar. 20, 1967, Proc. N.A.S., vol. 57, pp. 1331-1337.
Kolin, et al., "Miniaturization of the Electromagnetic Blood Flow Meter and Its Use for the Recording of Circulatory Responses of Conscious Animals to Sensory Stimuli", Department of Biophysics, University of California at Los Angeles, Aug. 1959, Proc. N.A.S. vol. 45(8), pp. 1312-1321.
Medtronic Activa Product Family and Procedure Solution Brochure, Medtronic, Inc, 2001.
Medtronic Neurostimulation Systems Brochure, Medtronic, Inc., 2002.
PCT/US2004/042081: Search Report and Written Opinion.
PCT/US2005/000322: Search Report and Written Opinion.
PCT/US2008/053540: Search Report and Written Opinion.
PCT/US2008/053541: Search Report and Written Opinion.
PCT/US2008/059358: Search Report and Written Opinion.
PCT/US2009/036461: Search Report and Written Opinion.
PCT/US2010/032516: Search Report and Written Opinion.
PCT/US2010/032526: Search Report and Written Opinion.
PCT/US2010/032543: Search Report and Written Opinion.
PCT/US2010/032560: Search Report and Written Opinion.
PCT/US2010/032567: Search Report and Written Opinion.
PCT/US2010/032666: Search Report and Written Opinion.
PCT/US2010/032671: Search Report and Written Opinion.
PCT/US2010/032675: Search Report and Written Opinion.
PCT/US2010/032682: Search Report and Written Opinion.
PCT/US2010/032719: Search Report and Written Opinion.
PCT/US2013/023637: Search Report and Written Opinion.
Quick et al., "Endourethral Mri", Magnetic Resonance in Medicine, 45:138-146, 2001.
Rezai, A., et al., "Neurostimulation System Used for Deep Brain Stimulation (DBS): MR Safety Issues and Implications of Failing to Follow Safety Recommendations" Investigative Radiology, May 2004, vol. 39, Issue 5, pp. 300-303.
Rezai, A., et al., "Neurostimulation Systems for Deep Brain Stimulation in Vitro Evaluation of Magnetic Resonance Imaging-Related Healing at 1.5 Tesla", Journal of Magnetic Reson. Imaging 2002; 15:241-50.
US20170368335A1 (en) 2017-12-28 application
US20150246222A1 (en) 2015-09-03 application
US20090234402A1 (en) 2009-09-17 application
US9037263B2 (en) 2015-05-19 grant
US7164950B2 (en) 2007-01-16 Implantable stimulation device with isolating system for minimizing magnetic induction
US20080269863A1 (en) 2008-10-30 Lead or lead extension having a conductive body and conductive body contact
US20060229693A1 (en) 2006-10-12 Medical electrical lead with co-radial multi-conductor coil
US20030083723A1 (en) 2003-05-01 Apparatus and method for shunting induced currents in an electrical lead
US20100280584A1 (en) 2010-11-04 Active implantable medical system having emi shielded lead
US20110160818A1 (en) 2011-06-30 Mri-conditionally safe medical device lead
US20080119917A1 (en) 2008-05-22 Electrode catheter for intervention purposes
US20070179582A1 (en) 2007-08-02 Polymer reinforced coil conductor for torque transmission
2017-07-11 AS Assignment
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MARSHALL, MARK T.;REEL/FRAME:042975/0613